Evidence map›Paper›PMID 41127046›Full record

ArticleInternational journal of general medicine2025

The Predictive Value of Liver/Spleen CT Value, BISAP Score Combined with Serum sPD-L1 for Hyperlipidemic Acute Pancreatitis.

Tao Liu, Lina Peng, Yifang Huo, Ting Lu, Xiaoping Lv

Abstract read
In one paragraph

Article in International journal of general medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Tao Liu *Department of Spleen, Stomach and Hepatology, Guangxi International Zhuang Medical Hospital, Nanning, Guangxi, People's Republic of China.
Lina Peng *Department of Spleen, Stomach and Hepatology, Guangxi International Zhuang Medical Hospital, Nanning, Guangxi, People's Republic of China.
Yifang HuoDepartment of Gastroenterology, Wuzhou Gongren Hospital, Wuzhou, Guangxi, People's Republic of China.
Ting LuDepartment of Spleen, Stomach and Hepatology, Guangxi International Zhuang Medical Hospital, Nanning, Guangxi, People's Republic of China.
Xiaoping LvDepartment of Gastroenterology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, People's Republic of China.ORCID 0009-0009-3428-8683

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To explore the predictive value of liver/spleen CT Value, bedside index for severity in acute pancreatitis (BISAP) score combined with serum soluble programmed death ligand 1 (sPD-L1) within 24 hours of onset for the severity tendency of hyperlipidemic acute pancreatitis (HTG-AP). Methods: A retrospective study was conducted on the clinical data of 102 patients with mild to moderate HTG-AP. These patients were divided into the progression group (24 cases) and the stable group (78 cases) based on whether they progressed to severe HTG-AP. The liver/spleen CT values, BISAP scores, serum sPD-L1 levels and blood urea nitrogen (BUN) levels were compared within 24 hours of onset in the two groups. The COX regression model was used to analyze the influencing factors of the tendency of HTG-AP severity. The predictive efficacy of each indicator was evaluated through the Receiver operating characteristic curves (ROC). Results: The BUN, BISAP score, serum sPD-L1 levels, and the proportion of moderate HTG-AP in the progression group were all higher than those in the stable group, while the liver/spleen CT values were lower than the stable group (all Conclusion: Liver/spleen CT values, BISAP scores and serum sPD-L1 have certain predictive value for the tendency of severe deterioration in patients with HTG-AP within 24 hours of onset. When these three factors are combined, the predictive efficacy is even better.

Indexed as

acute pancreatitisBISAP scorefatty liverhyperlipidemiaseveritysoluble programmed death ligand 1

Identifiers

PMID41127046
PMCPMC12537817

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.